American Society of Hirudotherapy

[Coagulation Monitoring using ROTEM(®): Pro].

Research article published in Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS (2011)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsFries · Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2011

Abstract

Coagulation and haemostasis in critical ill patients, either in massively bleeding patients in the emergency room and the operating theatre (TIC = trauma induced coagulopathy) or in septic patients suffering from multiorgan failure (DIC = disseminated intravascular coagulopathy) have to be identified and monitored promptly to initiate and monitor an effective therapy - either aggressive therapy using coagulation factor concentrates and blood products or a keen anticoagulation. Under this circumstances, standard coagulation monitoring using PT (INR), aPTT and fibrinogen (Clauss method) is limited. In critical ill patients, these parameters are neither able to predict risk of bleeding nor the risk of thrombosis. New viscoelastic methods like the ROTEM® may help to improve coagulation monitoring and management even in the emergency situation or under critical care conditions.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal Article
Indexed MeSH termsBlood Coagulation DisordersEquipment DesignHumansThrombelastography

Summary

[Coagulation Monitoring using ROTEM(®): Pro].

Why This Matters for Hirudotherapy

This article discusses the limitations of standard coagulation tests—PT (INR), aPTT, and fibrinogen by the Clauss method—in critically ill patients, noting that these parameters are neither able to predict risk of bleeding nor risk of thrombosis in massively bleeding or septic patients. The abstract states that new viscoelastic methods like ROTEM® may help improve coagulation monitoring and management in emergency situations and critical care conditions. The article addresses coagulation monitoring in trauma-induced coagulopathy and disseminated intravascular coagulopathy. The abstract contains no mention of leeches, hirudotherapy, hirudin, or the leech secretome, so any relevance to the American Society of Hirudotherapy is not supported by this article's content.

Citation

[Coagulation Monitoring using ROTEM(®): Pro].

Fries · Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2011

DOI

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.